DUBLIN–(BUSINESS WIRE)–The “D-Lysine Monohydrochloride (CAS 7274-88-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. This report on D-Lysine monohydrochloride provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth … [Read more…]

Clinic may provide effective ketamine therapy for those who haven’t responded to medication NOCATEE, Fla.–(BUSINESS WIRE)–Serenity Mental Health Centers, a leader in psychiatric care and one of the fastest growing mental health providers in the nation, today announced the expansion of its ketamine treatment in Nocatee. Serenity’s board-certified psychiatrists and psychiatric mental health nurse practitioners … [Read more…]

WASHINGTON–(BUSINESS WIRE)–#CommunityCare–Wellpoint DC (formerly Amerigroup District of Columbia) is starting the new year by announcing it has been awarded NCQA Health Outcomes Accreditation and NCQA Community-Focused Care Accreditation—formerly Health Equity Accreditation and Health Equity Accreditation Plus—for its Medicaid health plan. Combined with its NCQA Health Plan Accreditation earned in October 2025, this distinction makes Wellpoint … [Read more…]

LONDON & CAIRO–(BUSINESS WIRE)–Alta Semper, a London-based private equity firm focused on healthcare and consumer investments across growth markets, today announced that it has signed definitive agreements to acquire a majority stake in Nature’s Rule, a leading sports nutrition and dietary supplements company headquartered in the UAE, with an established manufacturing presence in Egypt. The … [Read more…]

Record iCRO bookings in 2025; order backlog at an all-time high of €76.6 million despite negative forex impact of € (6.5) million 2025 revenue of €23.5 million, up 2.6% vs 2024 despite negative forex impact of € (0.8) million FDA decision for eyonis® LCS expected in the coming weeks; CE marking anticipated in Q2 2026 … [Read more…]

JERSEY CITY, N.J.–(BUSINESS WIRE)–Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that the US Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for NEXPLANON® (etonogestrel implant), which is indicated for use by women of reproductive … [Read more…]

2 Night Only Art Exhibition in Hollywood, January 20 and 21, 6:00 p.m. – 9:00 p.m. LOS ANGELES–(BUSINESS WIRE)–“Bloom,” a multi-sensory art experience that converts two physical murals into living, breathing works of art, will land for a two night only exhibition in Hollywood, California, on Tuesday and Wednesday, January 20th and 21st. Created in … [Read more…]

Susan G. Komen® Applauds Bill Introduction, Urges Quick Passage PHOENIX–(BUSINESS WIRE)–Susan G. Komen®, the world’s leading breast cancer organization commends Senator Hildy Angius (R-Bullhead City) for introducing legislation to ensure equitable access to required diagnostic and supplemental breast imaging, by eliminating the financial barriers patients face in accessing needed breast cancer screening. The exorbitant out-of-pocket … [Read more…]

NEW YORK–(BUSINESS WIRE)–Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2025 fourth quarter and full year earnings conference call on Friday, January 30, 2026, at 8:30 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, and Chief Investor Relations Officer and EVP, M&A, … [Read more…]

Durable complete responses with CAR-NK + Rituximab in patients who failed current standards of care in Waldenstrom’s Non-Hodgkins lymphoma (NHL). Long-term evaluable patients demonstrate ongoing complete response of 7 and 15 months after receiving a total of eight doses four cycles of CD19 CAR-NK plus rituximab, with no further treatment thereafter The first chemotherapy free, … [Read more…]